Baker Brothers Advisors - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 56 filers reported holding VINCERX PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q2 2023$293,253
+16.8%
225,579
-6.5%
0.00%
+100.0%
Q1 2023$251,034
+2.0%
241,3790.0%0.00%0.0%
Q4 2022$246,207
-26.1%
241,3790.0%0.00%
-50.0%
Q3 2022$333,000
+4.4%
241,3790.0%0.00%0.0%
Q2 2022$319,000
-67.0%
241,3790.0%0.00%
-66.7%
Q1 2022$966,000
-60.7%
241,3790.0%0.01%
-50.0%
Q4 2021$2,460,000
-37.0%
241,3790.0%0.01%
-29.4%
Q3 2021$3,903,000241,3790.02%
Other shareholders
VINCERX PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,703,413$1,720,4470.48%
Tejara Capital Ltd 233,348$235,6810.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$388,8500.04%
SABBY MANAGEMENT, LLC 57,353$57,9270.04%
Long Focus Capital Management, LLC 1,098,753$1,109,7410.04%
Sio Capital Management, LLC 102,049$103,0690.03%
Rock Springs Capital Management LP 891,719$900,6360.02%
Rubric Capital Management LP 354,377$357,9210.01%
Clearline Capital LP 98,916$99,9050.01%
ExodusPoint Capital Management, LP 389,512$3930.00%
View complete list of VINCERX PHARMA INC shareholders